Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Conatus Pharmaceuticals Inc. (CNAT)

« Back to company index

CNAT Chatter Timeline

Stock Ticker for CNAT

Most Active Tweeters for CNAT

UserTweets
@bulletin_en 4
@TickerReport 2
@ZolmaxNews 2
@ramypandey 2
@MarkBagger 1

Recent Tweets for CNAT

bulletin_en @bulletin_en
Pacific Biosciences of California Inc. $CNAT https://t.co/92zBwBedES
May 23rd 2019, 6:05pm
registrarjourn @registrarjourn
Head to Head Review: Conatus Pharmaceuticals $CNAT & Vascular Biogenics $VBLT https://t.co/6LLDI69k23
May 23rd 2019, 1:05am
EnterpriseLeade @EnterpriseLeade
Head to Head Review: Conatus Pharmaceuticals $CNAT & Vascular Biogenics $VBLT https://t.co/ZgsI8XH8CN
May 23rd 2019, 1:05am
AmericanBanking @AmericanBanking
Conatus Pharmaceuticals $CNAT & Vascular Biogenics $VBLT Head to Head Contrast https://t.co/XE8S4nie95 #stocks
May 20th 2019, 8:05pm
ChartMill @ChartMill
$CNAT is cheaper than 85% of the companies listed in the same industry. https://t.co/7zG19V8EoZ https://t.co/zeZST4J5sV
May 20th 2019, 2:05pm
StockTipRobot @StockTipRobot
Upgrade to premium for real advice... dump all of Conatus Pharmaceuticals Inc. $CNAT #YOLO
May 20th 2019, 10:05am
bulletin_en @bulletin_en
Fortress Biotech Inc. $CNAT Comparison side by side https://t.co/X3aLFMt0H9
May 19th 2019, 9:05am
bulletin_en @bulletin_en
Curis Inc. $CNAT https://t.co/fZcERw6Dvm
May 18th 2019, 10:05am
Biotrade_alert @Biotrade_alert
Trade Alert: Sold $CNAT at $0.855 with 49% Loss
May 17th 2019, 1:05pm
FinZTribune @FinZTribune
Reviewing Alnylam Pharmaceuticals Inc. $CNAT's results https://t.co/M86RWVVUnj
May 16th 2019, 10:05pm
ATrader17 @ATrader17
Looks like $CNAT is priming for a decent move to the upside. Strong S/R in the .84/.86-.89 range. Holding at .90/.91 now.
May 16th 2019, 1:05pm
bulletin_en @bulletin_en
Paratek Pharmaceuticals Inc. $CNAT Contrasting side by side https://t.co/snPZuSLHD7
May 16th 2019, 1:05am
WKRBNews @WKRBNews
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Quarterly Sales of $8.87 Million https://t.co/u3Y7B7N5x2 #markets
May 15th 2019, 9:05pm
MarkBagger @MarkBagger
$CNAT .91 nice upwards trend here past 2-3 weeks $CNAT https://t.co/6BuHLIa9PC
May 15th 2019, 8:05pm
Stock_News_Now @Stock_News_Now
$CNAT: New SEC Filing for CNAT: Form 8-K (No. 0001193125-19-147983): https://t.co/fE3lyyqUht
May 15th 2019, 4:05pm
ramypandey @ramypandey
$cnat...there is potential
May 15th 2019, 11:05am
ramypandey @ramypandey
$cnat up nicely but volume still insignificant to make anything out of it
May 14th 2019, 1:05pm
ZolmaxNews @ZolmaxNews
Conatus Pharmaceuticals Inc $CNAT Expected to Post Earnings of -$0.10 Per Share https://t.co/1ANHzpZVmJ
May 13th 2019, 6:05pm
TickerReport @TickerReport
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Quarterly Sales of $8.87 Million https://t.co/7TdqV6ipKl
May 13th 2019, 6:05pm
ZolmaxNews @ZolmaxNews
Zacks: Brokerages Expect Conatus Pharmaceuticals Inc $CNAT Will Post Quarterly Sales of $8.87 Million https://t.co/8z5HWUA6aY
May 11th 2019, 10:05am
TickerReport @TickerReport
Conatus Pharmaceuticals Inc $CNAT Expected to Post Earnings of -$0.10 Per Share https://t.co/TKroOTX2S2
May 11th 2019, 10:05am
OTC_Observer @OTC_Observer
#StocksToTrade #stockstowatch ?WHY I’M FINALLY BUYING $VERB / CONATUS PHARMACEUTICALS INC. $CNAT ??… https://t.co/NqoaZxcwx9
May 9th 2019, 12:05pm
ThisLincolnian @ThisLincolnian
Conatus Pharmaceuticals Inc $CNAT Expected to Announce Earnings of -$0.09 Per Share https://t.co/RKi57wyrg7
May 9th 2019, 9:05am
VGaykin @VGaykin
$CNAT https://t.co/LxiqQWRiRg
May 9th 2019, 12:05am
TradeFlags @TradeFlags
TD SELL $CNAT at 0.92, Supp 0.75 Resis 0.94 R26 HiLo 4% T1Y 2 hold 3.0 fwdPE -1.8 DIV N/A #Conatus Ph #stocks… https://t.co/cTU0IXwwi5
May 8th 2019, 10:05pm
MarkBagger @MarkBagger
$CNAT .92 nice recovery today after morning dip $CNAT https://t.co/kAlXZRk6rZ
May 8th 2019, 10:05pm
ChartMill @ChartMill
A Current Ratio of 2.56 indicates that $CNAT has no problem at all paying its short term obligations.… https://t.co/nPe6uBh5Of
May 8th 2019, 5:05pm
AmericanBanking @AmericanBanking
Analysts Expect Conatus Pharmaceuticals Inc $CNAT Will Post Quarterly Sales of $9.49 Million https://t.co/HZOKzWCG2n #stocks
May 8th 2019, 2:05am
ConsumerFeed @ConsumerFeed
Zacks: Brokerages Anticipate Conatus Pharmaceuticals Inc $CNAT Will Announce Quarterly Sales of $9.49 Million https://t.co/K8LgRErBEL
May 8th 2019, 2:05am
dispatchtribune @dispatchtribune
Contrasting Conatus Pharmaceuticals $CNAT and Synergy Pharmaceuticals $SGYP https://t.co/qr9DZU5hlk
May 7th 2019, 12:05pm
FinZTribune @FinZTribune
Comparison of Gritstone Oncology Inc. $CNAT https://t.co/2RttPEgDaN
May 7th 2019, 6:05am
TranscriptDaily @TranscriptDaily
HC Wainwright Reaffirms “Hold” Rating for Conatus Pharmaceuticals $CNAT https://t.co/CpJ4V0vQ4K
May 7th 2019, 6:05am
dakotafinancial @dakotafinancial
HC Wainwright Reaffirms “Hold” Rating for Conatus Pharmaceuticals $CNAT https://t.co/M0jYVsSn8D
May 7th 2019, 6:05am
MarkBagger @MarkBagger
$CNAT .94 moving nicely off bottom, nice consolidation, good longer term swing imo $CNAT https://t.co/N2Yx6Y8yJY
May 6th 2019, 8:05pm
AmericanBanking @AmericanBanking
Brokerages Expect Conatus Pharmaceuticals Inc $CNAT Will Announce Earnings of -$0.07 Per Share https://t.co/mH1qXSBQT6 #stocks
May 6th 2019, 6:05pm
dailypoliticaln @dailypoliticaln
-$0.07 Earnings Per Share Expected for Conatus Pharmaceuticals Inc $CNAT This Quarter https://t.co/pnnBDQxHJr
May 6th 2019, 6:05pm
macondailynews @macondailynews
Conatus Pharmaceuticals Inc $CNAT Receives $4.30 Average PT from Analysts https://t.co/97AOz6TDye
May 6th 2019, 5:05pm
OlympiaReport @OlympiaReport
Conatus Pharmaceuticals $CNAT Shares Up 2.2% https://t.co/0XzAgfmjS3
May 6th 2019, 2:05pm
SleekMoneycom @SleekMoneycom
Conatus Pharmaceuticals’ $CNAT “Hold” Rating Reiterated at HC Wainwright https://t.co/Rqi8DmfDQI #investing
May 6th 2019, 5:05am
stocknewstimes @stocknewstimes
Conatus Pharmaceuticals’ $CNAT “Hold” Rating Reiterated at HC Wainwright https://t.co/KPifCExywb
May 6th 2019, 5:05am
OlympiaReport @OlympiaReport
Conatus Pharmaceuticals $CNAT Earns Hold Rating from HC Wainwright https://t.co/L4PNCGtjmI
May 5th 2019, 9:05pm
TheMarketsDaily @TheMarketsDaily
HC Wainwright Reaffirms “Hold” Rating for Conatus Pharmaceuticals $CNAT https://t.co/7zjFGPmAky
May 4th 2019, 4:05pm
OlympiaReport @OlympiaReport
Conatus Pharmaceuticals Inc $CNAT Receives Consensus Recommendation of “Hold” from Analysts https://t.co/gMXmtNqTa0
May 4th 2019, 12:05pm
FinZTribune @FinZTribune
Array BioPharma Inc. $CNAT Comparing side by side https://t.co/Kv5zxgDCtc
May 3rd 2019, 7:05pm
Stock_News_Now @Stock_News_Now
$CNAT: New SEC Filing for CNAT: Form 10-Q (No. 0001564590-19-015689): https://t.co/p0c4EFBv2s
May 3rd 2019, 4:05pm
confcalltran @confcalltran
Conatus Pharmaceuticals Just Filed Its Quarterly Report: Net Loss Per ShareB... https://t.co/V54iUvaNrO $CNAT
May 3rd 2019, 4:05pm
registrarjourn @registrarjourn
Conatus Pharmaceuticals $CNAT Releases Earnings Results https://t.co/skIW1boaUC
May 3rd 2019, 3:05pm
EnterpriseLeade @EnterpriseLeade
Conatus Pharmaceuticals $CNAT Releases Earnings Results https://t.co/7a4hwPoezB
May 3rd 2019, 3:05pm
AmericanBanking @AmericanBanking
Conatus Pharmaceuticals $CNAT Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS https://t.co/Q7ofEjX9jc #stocks
May 3rd 2019, 3:05pm
momzdaytrading @momzdaytrading
$CNAT climbing
May 3rd 2019, 2:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.